Terkko Navigator / Movement Disorders

A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease

Pathogenesis‐targeted therapeutic strategies in Parkinson's disease

MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy

Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

Wild‐type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease

Identification of a large homozygous VPS13C deletion in a patient with early‐onset Parkinsonism

Anle138b modulatesα‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy

MRI‐guided laser interstitial thermal thalamotomy for medically intractable tremor disorders

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease

Progressively Disrupted Somatodendritic Morphology in Dopamine Neurons in a Mouse Parkinson's Model

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

BDNF provides many routes toward STN DBS‐mediated disease modification

Pallidal beta bursts in Parkinson's disease and dystonia

Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus

Glial GLP1R: A novel neuroprotector?

Anodal tDCS over prefrontal cortex improves dual‐task walking in Parkinsonian patients with freezing

Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study

Prodromal features of Parkinson's disease: Self‐reported symptoms versus clinically assessed signs

Parkinsonism due to A53Eα‐synuclein gene mutation: Clinical, genetic, epigenetic, and biochemical features

Ultra‐high‐frequency deep brain stimulation at 10,000 Hz improves motor function

Sensingα‐Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration

Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI

MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy

Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

Wild‐type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease

Identification of a large homozygous VPS13C deletion in a patient with early‐onset Parkinsonism

Anle138b modulatesα‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy

MRI‐guided laser interstitial thermal thalamotomy for medically intractable tremor disorders

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease

Progressively Disrupted Somatodendritic Morphology in Dopamine Neurons in a Mouse Parkinson's Model

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

BDNF provides many routes toward STN DBS‐mediated disease modification

Pallidal beta bursts in Parkinson's disease and dystonia

Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus

Glial GLP1R: A novel neuroprotector?

Anodal tDCS over prefrontal cortex improves dual‐task walking in Parkinsonian patients with freezing

Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study

Prodromal features of Parkinson's disease: Self‐reported symptoms versus clinically assessed signs

Parkinsonism due to A53Eα‐synuclein gene mutation: Clinical, genetic, epigenetic, and biochemical features

Ultra‐high‐frequency deep brain stimulation at 10,000 Hz improves motor function

Sensingα‐Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration

Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI

Abnormal sensory gating in patients with different types of focal dystonias

Abnormal sensory gating in patients with different types of focal dystonias

PTRHD1 Loss‐of‐function mutation in an african family with juvenile‐onset Parkinsonism and intellectual disability

Familial ataxia, tremor, and dementia in a polish family with a novel mutation in the CCDC88C gene

Mediterranean diets and prodromal Parkinson's disease: A causal line, or a confound circle?

Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board

Diet to beat the odds of prodromal Parkinson's disease?

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive‐enhancing medications